Today: 9 April 2026
Quantum computing stocks slide into weekend: D-Wave, Rigetti, IonQ retreat as filings and Fed week loom

Quantum computing stocks slide into weekend: D-Wave, Rigetti, IonQ retreat as filings and Fed week loom

New York, January 24, 2026, 12:35 EST — The market has closed.

  • D-Wave, Rigetti, IonQ and Quantum Computing Inc dropped between 4% and 7% on Friday.
  • D-Wave’s filings kept dilution concerns alive, while Rigetti’s India order remained a hotspot following an analyst upgrade
  • Traders are now focused on the Fed meeting scheduled for Jan. 27-28, along with new corporate earnings reports

Quantum computing stocks listed in the U.S. closed the week on a down note Friday. D-Wave Quantum took the biggest hit, sliding 6.5% to $25.63. Rigetti Computing wasn’t far behind, down 5.9% at $23.45. IonQ slipped 4.3% to $47.25, while Quantum Computing Inc dropped 4.4%, ending at $11.46.

This matters now because the group behaves like a tight-knit bunch of high-risk growth plays. Their small revenue and hefty spending mean even slight shifts in funding outlook can send prices sharply moving.

Next week will put risk appetite to the test. The Federal Reserve meets Jan. 27-28, with a rate decision set for Wednesday afternoon, followed by Chair Jerome Powell’s press conference — both closely watched for their impact on speculative tech stocks. Federal Reserve

On the corporate front, D-Wave has been busy with filings. It submitted documents related to a shelf registration and revealed a prospectus supplement outlining the possible resale of 10,430,444 common shares by some selling stockholders, according to an SEC filing. SEC

A shelf registration doesn’t require an immediate sale. Still, the possibility of additional shares hitting the market looms, often limiting rallies as traders look to lock in profits.

Rigetti got a boost earlier this week when B. Riley upgraded the stock from “Neutral” to “Buy,” maintaining a $35 price target. The move came after the company announced an $8.4 million order from India’s C-DAC. According to Investing.com, B. Riley said the deal “enhanced full-year estimate attainment visibility.” Investing.com

D-Wave announced on Jan. 20 that it has finalized its acquisition of Quantum Circuits Inc. The company plans to reveal its dual-platform roadmap at the Qubits 2026 event, set for Jan. 27-28 in Boca Raton, Florida. CEO Alan Baratz described the deal as “a watershed moment” in a company statement. D-Wave Quantum

IonQ CEO Niccolo De Masi threw out a stark warning in Davos: “Q-Day”—the moment quantum computers can crack common encryption—might come within three years. That puts a spotlight on post-quantum security budgets, despite ongoing debate over the exact timing. The Economic Times

The broader outlook also softened. The Defiance Quantum ETF dropped 0.6% on Friday, less steep than the declines seen in most pure-play stocks.

That said, the risk cuts both ways. Tech firms burning cash are usually the first to feel the pinch when financial conditions tighten or equity volatility resurfaces, and quantum stocks often swing too far, up or down.

When U.S. markets reopen Monday, investors will be on the lookout for prospectus supplements linked to D-Wave’s registration. They’ll also watch for fresh contract disclosures across the group. The next major trigger is the Fed’s policy statement on Jan. 28 at 2:00 p.m. ET, a key event that often shifts the mood for high-beta stocks. Investing.com

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Big Tech stocks brace for earnings week as Microsoft jumps and Nvidia firms on China chip signal
Previous Story

Big Tech stocks brace for earnings week as Microsoft jumps and Nvidia firms on China chip signal

Space and defense stocks face earnings week after Karman outlook bump, AST launch plan
Next Story

Space and defense stocks face earnings week after Karman outlook bump, AST launch plan

Go toTop